Takip et
Marcello Turi
Marcello Turi
Candiolo Cancer Institute - FPO - IRCCS
ircc.it üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Intercellular mitochondrial transfer in the tumor microenvironment
H Sahinbegovic, T Jelinek, M Hrdinka, JR Bago, M Turi, T Sevcikova, ...
Cancers 12 (7), 1787, 2020
432020
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
P Celichowski, M Turi, S Charvátová, D Radhakrishnan, N Feizi, Z Chyra, ...
Journal of Translational Medicine 21 (1), 197, 2023
242023
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
A Vdovin, T Jelinek, D Zihala, T Sevcikova, M Durech, H Sahinbegovic, ...
Nature Communications 13 (1), 6820, 2022
162022
Transcriptome analysis of diffuse large b-cell lymphoma cells inducibly expressing MyD88 L265P mutation identifies upregulated CD44, LGALS3, NFKBIZ, and BATF as downstream …
M Turi, A Anilkumar Sithara, L Hofmanová, D Žihala, D Radhakrishnan, ...
International Journal of Molecular Sciences 24 (6), 5623, 2023
142023
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma
A Gulla, E Morelli, M Johnstone, M Turi, MK Samur, C Botta, S Cifric, ...
Blood 143 (25), 2612-2626, 2024
72024
Promises and challenges of immunogenic chemotherapy in multiple myeloma
M Johnstone, D Vinaixa, M Turi, E Morelli, KC Anderson, A Gulla
Cells 11 (16), 2519, 2022
52022
DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic Chemotherapy
S Cifric, M Turi, P Folino, C Clericuzio, F Barello, T Maciel, KC Anderson, ...
Antioxidants & Redox Signaling, 2024
22024
Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation
D Radhakrishnan, J Kotulová, L Hofmanová, AA Sithara, M Turi, D Žihala, ...
Journal of Leukocyte Biology 117 (1), qiae184, 2025
2025
A Novel Ribonuclease Targeting Small Molecule RNA-Degrader (MYC-RiboTAC) Overcomes MYC Dependency in Multiple Myeloma
D Maisano, T Wang, Y Tong, V Favasuli, N Liu, C Gao, C Chakraborty, ...
Blood 144, 3268, 2024
2024
Isoform-Level Long Noncoding RNA Dependencies in Multiple Myeloma
E Morelli, A Aktas-Samur, D Maisano, C Gao, V Favasuli, D Papaioannou, ...
Blood 144, 4130, 2024
2024
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model
S Parab, V Sarlo, S Capellero, L Palmiotto, A Bartolini, D Cantarella, ...
International Journal of Molecular Sciences 25 (20), 11228, 2024
2024
Abstract P24: GABARAP deficiency drives resistance to immunogenic chemotherapy in multiple myeloma
M Turi, E Morelli, M Johnstone, MK Samur, C Botta, S Cifric, P Folino, ...
Blood Cancer Discovery 5 (2_Supplement), P24-P24, 2024
2024
Abstract P37: Decoding Cancer Dependency and Molecular Pathways of Long Noncoding RNAs with a Novel CRISPR-Cas13d Platform
E Morelli, A Aktas-Samur, D Maisano, C Gao, N Liu, V Favasuli, M Turi, ...
Blood Cancer Discovery 5 (2_Supplement), P37-P37, 2024
2024
CRISPR-Based Functional Transcriptomics Defines the Tumor-Dependency and Molecular Determinants of Long Noncoding RNAs in Multiple Myeloma
E Morelli, A Aktas-Samur, D Maisano, C Gao, N Liu, V Favasuli, M Turi, ...
Blood 142, 640, 2023
2023
P-195 Loss of GABARAP mediates resistance to immunogenic chemotherapy by altering protein trafficking of calreticulin on the cell surface
A Gulla, E Morelli, M Johnstone, M Turi, M Samur, C Botta, S Cifric, ...
Clinical Lymphoma Myeloma and Leukemia 23, S143, 2023
2023
PB2397: TRANSCRIPTOME ANALYSIS OF DIFFUSE LARGE B-CELL LYMPHOMA CELLS EXPRESSING MYD88 L265P REVEALS CD44, LGALS3, NFKBIZ AND BATF AS DOWNSTREAM TARGETS OF ONCOGENIC NF-ΚB …
M Turi, AA Sithara, L Hofmanová, D Žihala, D Radhakrishnan, A Vdovin, ...
HemaSphere 7 (S3), e4265786, 2023
2023
Targeting Autophagy to Overcome Resistance to Immunogenic Chemotherapy in High-Risk Multiple Myeloma
A Gulla, E Morelli, MK Samur, M Johnstone, C Botta, D Vinaixa, M Turi, ...
Blood 140 (Supplement 1), 7114-7115, 2022
2022
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–17